<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01493362</url>
  </required_header>
  <id_info>
    <org_study_id>#5175</org_study_id>
    <secondary_id>R01MH079397</secondary_id>
    <nct_id>NCT01493362</nct_id>
  </id_info>
  <brief_title>Imaging the Dopamine Systems in Bulimia Nervosa</brief_title>
  <official_title>Imaging the Dopamine Systems in Bulimia Nervosa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York State Psychiatric Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>New York State Psychiatric Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will use positron emission tomography imaging to investigate the dopamine systems
      in people with bulimia nervosa.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>D2 receptor density</measure>
    <time_frame>Measured at baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>DA release in the striatum</measure>
    <time_frame>Measures after Mythlyphenidate challenge</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">33</enrollment>
  <condition>Eating Disorders</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Participants with Bulimia Nervosa</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Participants who are healthy controls</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will include people with bulimia nervosa seeking inpatient or
        outpatient treatment and people who will act as healthy control participants
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Participants with BN:

          -  Meets DSM-IV criteria for BN

          -  Sufficiently medically and psychiatrically stable to participate in research

        Health Control Participants:

          -  No current or past psychiatric illness

          -  Between 80% and 120% of ideal body weight

        Exclusion Criteria:

        All participants:

          -  Current use of psychotropic medication such as anti psychotics or antidepressants

          -  Pregnant or breastfeeding

          -  history of substance abuse

          -  Significant medical illness

          -  High blood pressure (resting systolic blood pressure greater than 150mmHg and
             diastolic blood pressure greater that 90 mmHg)

          -  Current or lifetime history of schizophrenia, bipolar disorder, or other psychotic
             disorder as defined by DSM-IV

          -  Metal implants or paramagnetic objects contained within the body that may interfere
             with the MRI scan, as determined in consultation with a neuroradiologist and according
             to specified reference book guidelines

          -  Exposed to radiation in the workplace or has had a nuclear medicine procedure during
             the 1 year before study entry

          -  Previous adverse reaction to psycho stimulants
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>New York State Psychiatric Institute</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2011</study_first_submitted>
  <study_first_submitted_qc>December 14, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2011</study_first_posted>
  <last_update_submitted>August 14, 2014</last_update_submitted>
  <last_update_submitted_qc>August 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bulimia Nervosa</keyword>
  <keyword>PET Imaging</keyword>
  <keyword>Dopamine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Feeding and Eating Disorders</mesh_term>
    <mesh_term>Bulimia</mesh_term>
    <mesh_term>Bulimia Nervosa</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dopamine</mesh_term>
    <mesh_term>Dopamine Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

